Scopia Capital Management 13F holdings, Q3 2019
Holdings as of September 30, 2019 · filings on SEC EDGAR · latest filing →
Scopia Capital Management disclosed 22 US equity positions worth $1.6bn in its Q3 2019 13F filing. The largest position was S9Q at 13.7% of the reported book, followed by VST and JCI. Against the Q2 2019 filing, it opened 4 new positions, added to 5 and reduced 9 among the top 22 holdings.
What did Scopia Capital Management own in Q3 2019? Top 22 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2019 |
|---|---|---|---|---|---|---|---|
| 1 | S9Q SPIRIT AEROSYSTEMS HLDGS INC | 13.7% | $222.6m | 2,707,197 | 6% | added | |
| 2 | VST VISTRA ENERGY CORP | Utilities | 11.7% | $190.4m | 7,123,927 | -40% | reduced |
| 3 | JCI JOHNSON CTLS INTL PLC | Industrials | 9.5% | $154.4m | 3,517,264 | -12% | reduced |
| 4 | ITRI ITRON INC | Technology | 8.8% | $142.0m | 1,920,540 | -41% | reduced |
| 5 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 8.2% | $133.6m | 798,691 | – | new |
| 6 | VONAGE HLDGS CORP | 8.1% | $132.1m | 11,693,319 | 33% | added | |
| 7 | HORIZON THERAPEUTICS PUB LTD | 7.1% | $115.0m | 4,221,585 | -2% | reduced | |
| 8 | NXPI NXP SEMICONDUCTORS N V | Technology | 7.0% | $113.5m | 1,040,298 | 16% | added |
| 9 | WELBILT INC | 6.8% | $110.6m | 6,559,589 | 14% | added | |
| 10 | ZOGENIX INC | 3.9% | $64.0m | 1,598,051 | 12% | added | |
| 11 | UPWK UPWORK INC | Communication Services | 3.6% | $58.3m | 4,381,052 | – | new |
| 12 | HEADHUNTER GROUP PLC | 2.5% | $40.9m | 2,120,110 | -3% | reduced | |
| 13 | RETROPHIN INC | 2.3% | $37.3m | 3,219,898 | -17% | reduced | |
| 14 | HLIT HARMONIC INC | Technology | 2.1% | $33.8m | 5,129,642 | -16% | reduced |
| 15 | PTCT PTC THERAPEUTICS INC | Healthcare | 1.8% | $29.5m | 871,780 | -11% | reduced |
| 16 | WRIGHT MED GROUP N V | 1.2% | $19.2m | 932,333 | – | new | |
| 17 | ACORDA THERAPEUTICS INC | 0.5% | $8.0m | 2,773,777 | -17% | reduced | |
| 18 | PROSPECT CAPITAL CORPORATION | 0.4% | $7.2m | 1,085,322 | – | new | |
| 19 | FOSL FOSSIL GROUP INC | Consumer Cyclical | 0.3% | $5.0m | 395,925 | 0% | held |
| 20 | INTERCEPT PHARMACEUTICALS IN | 0.2% | $3.8m | 56,794 | 0% | held | |
| 21 | MNKD MANNKIND CORP | Healthcare | 0.1% | $1.2m | 933,612 | 0% | held |
| 22 | AMSC AMERICAN SUPERCONDUCTOR CORP | Industrials | 0.0% | $154.0k | 19,610 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.